PortfoliosLab logoPortfoliosLab logo
AMSC vs. ADMA
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

AMSC vs. ADMA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in American Superconductor Corporation (AMSC) and ADMA Biologics, Inc. (ADMA). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, AMSC achieves a 44.65% return, which is significantly higher than ADMA's -52.36% return. Over the past 10 years, AMSC has outperformed ADMA with an annualized return of 17.66%, while ADMA has yielded a comparatively lower 2.29% annualized return.


AMSC

1D
-8.15%
1M
-19.70%
YTD
44.65%
6M
31.04%
1Y
28.41%
3Y*
92.13%
5Y*
18.67%
10Y*
17.66%

ADMA

1D
1.40%
1M
5.46%
YTD
-52.36%
6M
-55.41%
1Y
-51.37%
3Y*
30.95%
5Y*
39.41%
10Y*
2.29%
*Multi-year figures are annualized to reflect compound growth (CAGR)

AMSC vs. ADMA - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
AMSC
American Superconductor Corporation
44.65%16.85%121.10%202.72%-66.18%-53.54%198.34%-29.60%207.16%-50.75%
ADMA
ADMA Biologics, Inc.
-52.36%6.36%279.42%16.49%175.18%-27.69%-51.25%67.36%-25.55%-37.30%

Correlation

The correlation between AMSC and ADMA is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.11

Correlation (3Y)
Calculated over the trailing 3-year period

0.29

Correlation (5Y)
Calculated over the trailing 5-year period

0.29

Correlation (10Y)
Calculated over the trailing 10-year period

0.25

Correlation (All Time)
Calculated using the full available price history since Oct 17, 2013

0.21

The correlation between AMSC and ADMA shifts across timeframes, from 0.11 (1 year) to 0.29 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

AMSC:

$1.95B

ADMA:

$2.09B

EPS

AMSC:

$3.05

ADMA:

$0.68

PE Ratio

AMSC:

13.66

ADMA:

12.84

PS Ratio

AMSC:

6.11

ADMA:

4.16

PB Ratio

AMSC:

3.50

ADMA:

5.34

Total Revenue (TTM)

AMSC:

$299.15M

ADMA:

$509.86M

Gross Profit (TTM)

AMSC:

$91.38M

ADMA:

$312.42M

EBITDA (TTM)

AMSC:

$19.29M

ADMA:

$218.74M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

AMSC vs. ADMA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AMSC
AMSC Risk / Return Rank: 5555
Overall Rank
AMSC Sharpe Ratio Rank: 5454
Sharpe Ratio Rank
AMSC Sortino Ratio Rank: 5757
Sortino Ratio Rank
AMSC Omega Ratio Rank: 5858
Omega Ratio Rank
AMSC Calmar Ratio Rank: 5353
Calmar Ratio Rank
AMSC Martin Ratio Rank: 5151
Martin Ratio Rank

ADMA
ADMA Risk / Return Rank: 77
Overall Rank
ADMA Sharpe Ratio Rank: 66
Sharpe Ratio Rank
ADMA Sortino Ratio Rank: 88
Sortino Ratio Rank
ADMA Omega Ratio Rank: 88
Omega Ratio Rank
ADMA Calmar Ratio Rank: 1111
Calmar Ratio Rank
ADMA Martin Ratio Rank: 44
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AMSC vs. ADMA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for American Superconductor Corporation (AMSC) and ADMA Biologics, Inc. (ADMA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


AMSCADMADifference
Sharpe ratioReturn per unit of total volatility

+1.29

Sortino ratioReturn per unit of downside risk

+2.35

Omega ratioGain probability vs. loss probability

1.14

0.82

+0.32

Calmar ratioReturn relative to maximum drawdown

0.47

-0.82

+1.29

Martin ratioReturn relative to average drawdown

0.77

-1.64

+2.41

AMSC vs. ADMA - Sharpe Ratio Comparison

The current AMSC Sharpe Ratio is 0.33, which is higher than the ADMA Sharpe Ratio of -0.95. The chart below compares the historical Sharpe Ratios of AMSC and ADMA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

AMSC vs. ADMA - Drawdown Comparison

The maximum AMSC drawdown since its inception was -99.57%, which is greater than ADMA's maximum drawdown of -91.28%. Use the drawdown chart below to compare losses from any high point for AMSC and ADMA.


Loading charts...

Drawdown Indicators


AMSCADMADifference

Max Drawdown

Largest peak-to-trough decline

-99.57%

-91.28%

-8.29%

Max Drawdown (1Y)

Largest decline over 1 year

-61.08%

-62.71%

+1.63%

Max Drawdown (3Y)

Largest decline over 3 years

-63.86%

-68.99%

+5.13%

Max Drawdown (5Y)

Largest decline over 5 years

-82.94%

-68.99%

-13.95%

Max Drawdown (10Y)

Largest decline over 10 years

-89.06%

-86.11%

-2.95%

Current Drawdown

Current decline from peak

-93.99%

-64.55%

-29.44%

Average Drawdown

Average peak-to-trough decline

-75.77%

-53.07%

-22.70%

Ulcer Index

Depth and duration of drawdowns from previous peaks

36.89%

31.44%

+5.45%

Volatility

AMSC vs. ADMA - Volatility Comparison

American Superconductor Corporation (AMSC) has a higher volatility of 24.07% compared to ADMA Biologics, Inc. (ADMA) at 10.26%. This indicates that AMSC's price experiences larger fluctuations and is considered to be riskier than ADMA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


AMSCADMADifference

Volatility (1M)

Calculated over the trailing 1-month period

24.07%

10.26%

+13.81%

Volatility (6M)

Calculated over the trailing 6-month period

55.28%

45.76%

+9.52%

Volatility (1Y)

Calculated over the trailing 1-year period

85.75%

54.14%

+31.61%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

87.47%

59.49%

+27.98%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

79.25%

69.07%

+10.18%

Dividends

AMSC vs. ADMA - Dividend Comparison

Neither AMSC nor ADMA has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

AMSC vs. ADMA - Financials Comparison

This section allows you to compare key financial metrics between American Superconductor Corporation and ADMA Biologics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


20.00M40.00M60.00M80.00M100.00M120.00M140.00M20222023202420252026
86.41M
114.49M
(AMSC) Total Revenue
(ADMA) Total Revenue
Values in USD except per share items

AMSC vs. ADMA - Profitability Comparison

The chart below illustrates the profitability comparison between American Superconductor Corporation and ADMA Biologics, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

-20.0%0.0%20.0%40.0%60.0%80.0%20222023202420252026
27.3%
70.5%
Portfolio components
AMSC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, American Superconductor Corporation reported a gross profit of 23.60M and revenue of 86.41M. Therefore, the gross margin over that period was 27.3%.

ADMA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, ADMA Biologics, Inc. reported a gross profit of 80.75M and revenue of 114.49M. Therefore, the gross margin over that period was 70.5%.

AMSC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, American Superconductor Corporation reported an operating income of -522.00K and revenue of 86.41M, resulting in an operating margin of -0.6%.

ADMA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, ADMA Biologics, Inc. reported an operating income of 58.27M and revenue of 114.49M, resulting in an operating margin of 50.9%.

AMSC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, American Superconductor Corporation reported a net income of 4.53M and revenue of 86.41M, resulting in a net margin of 5.2%.

ADMA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, ADMA Biologics, Inc. reported a net income of 45.33M and revenue of 114.49M, resulting in a net margin of 39.6%.


Frequently Asked Questions


AMSC and ADMA have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

AMSC has higher volatility (24.07%) compared to ADMA (10.26%). In terms of maximum drawdown, AMSC dropped -99.57% vs ADMA's -91.28%.

AMSC currently has the higher Sharpe Ratio (0.33 vs -0.95), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for AMSC and ADMA

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer